Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-5,000
Closed -$210K 153
2016
Q1
$210K Sell
5,000
-5,000
-50% -$196K 0.11% 129
2015
Q4
$441K Buy
10,000
+2,500
+33% +$108K 0.26% 68
2015
Q3
$358K Hold
7,500
0.21% 74
2015
Q2
$437K Sell
7,500
-5,220
-41% -$281K 0.24% 68
2015
Q1
$642K Hold
12,720
0.35% 61
2014
Q4
$572K Hold
12,720
0.33% 60
2014
Q3
$469K Hold
12,720
0.26% 71
2014
Q2
$562K Hold
12,720
0.31% 63
2014
Q1
$553K Sell
12,720
-3,000
-19% -$134K 0.34% 59
2013
Q4
$673K Hold
15,720
0.39% 60
2013
Q3
$534K Hold
15,720
0.32% 64
2013
Q2
$491K Buy
+15,720
New +$510K 0.31% 64

Other funds holding CNMD

FCA Corp's CNMD Position: Q2 2016 in Review

FCA Corp sold out of CONMED (CNMD) in Q2 2016, closing a stake of 5,000 shares — an estimated $210K sold.

FCA Corp first reported a position in CNMD in Q2 2013 and held it in 12 quarters. The position peaked at $673K in Q4 2013. 155 funds tracked by Wall St. Rank hold CNMD as of Q2 2016.

  • FCA Corp reported no remaining CONMED position as of Q2 2016 after selling out during the quarter.
  • FCA Corp sold 5,000 CONMED shares in Q2 2016, an estimated $210K.
  • FCA Corp first reported a position in CONMED in Q2 2013 and held it in 12 quarters.
  • FCA Corp's CONMED position peaked at $673K in Q4 2013.
  • 155 funds tracked by Wall St. Rank held CONMED as of Q2 2016.

Based on FCA Corp's 13F filing for Q2 2016, filed 5 Aug 2016.